The government said Thursday that it would decide whether to grant emergency use authorization (EUA) for oral Covid-19 treatments by next week."The Ministry of Food and Drug Safety will review granting EUA by the end of this year," Kim Ok-soo, head of resource support team at Central Disease Control
inno.N said the company has licensed out its gastroesophageal reflux disease (GERD) therapy, K-CAB, to Braintree Laboratories, a subsidiary of Sebela US, a U.S.-based pharmaceutical company.The total contract size is 640 billion won ($540 million), the largest single contract achieved by the company
A research team at CHA Gangnam Medical Center has successfully conducted the world's first per-oral endoscopic esophagomyotomy (POEM) surgery on an infant with esophageal ataxia.According to the hospital, the infant was diagnosed with esophageal stenosis at another university hospital due to vomitin
Asan Medical Center (AMC) said Thursday that its researchers have developed a technology that can monitor the movement and survival of transplanted stem cells in real-time.Research on stem cell therapy has become active recently. The treatment has received attention as an alternative therapy method
The speed of vaccination is getting faster in Korea, indicating quarantine authorities’ all-out drive is gaining traction among the public, officials said.More than 60 percent of people aged 60 or older have been fully vaccinated and received booster shots, and the number of teenagers getting at lea
The government has sharply strengthened social distancing rules to contain resurging Covid-19 cases, but protests by small business owners and self-employed people are growing fiercer.Quarantine officials re-imposed a set of revised virus restrictions across the country from last Saturday to Jan. 2.
In January every year, all eyes of global biopharmaceutical companies are on the J.P. Morgan Health Conference, the largest healthcare conference in the world that draws institutional investors’ attention worldwide.For the same reason, many Korean drugmakers will participate in the 2022 conference d
GI Innovation said it has entered a clinical collaboration agreement with AstraZeneca to develop a combination therapy of GI-101 and Imfinzi.Under the accord, GI Innovation and AstraZeneca will conduct clinical trials assessing a combination regimen between GI-101 and Imfinzi to treat small cell lun
AT Sens said that it has signed a contract with Japan Lifeline, a Japanese cardiovascular medical device distribution company, to export AT-Patch, a continuous, long-term use electrocardiogram (ECG) device.Under the accord, AT Sens will export about 27.8 billion won ($23.7 million) worth of AT-Patch
The quarantine authorities predicted Monday that the Omicron variant might also emerge as the dominant strain in Korea in one or two months."There is a possibility that Omicron variant may become the dominant Covid-19 virus in a month or two here," said Lee Sang-won, director of epidemiological inve
After Merck released the results of its phase 3 clinical trial for molnupiravir, an oral Covid-19 treatment, investors are focusing their attention on how the results will affect related stocks in the Korean market.Merck is known as MSD outside of the U.S. and Canada.The phase 3 clinical trial resul
LG Chem said that Transthera Bioscience, its Chinese partner, has received approval from the Chinese National Medical Products Administration (NMPA) to conduct a phase 2 clinical trial into LC510255, an autoimmune disease treatment candidate.LG Chem will receive an undisclosed milestone from Transth
Maria Trading, one of the leading medical device distributors in the United Arab Emirates (UAE), said it has partnered up with a Korean company, NEO Dr., to supply the latest medical aesthetic products to the Arabic Gulf region.Under the accord, Maria Trading will not only supply NEO Dr.’s Mono & Co
The International Vaccine Institute (IVI) said that it has signed a memorandum of understanding with Sweden’s Ministry for Foreign Affairs to establish its regional office in Stockholm.With the opening of the new office, IVI aims to create an international hub for global health research, innovation,
A research team at the Korea Institute of Bioscience and Biotechnology (KRIBB) has identified the mechanism of promoting kidney damage and systemic inflammation of a protein toxin that causes the hemolytic uremic syndrome.The research team, led by Doctors Lee Moo-sung and Park Sung-kyun, found that
The government announced compensation measures to 3.2 million small businesses whose sales have decreased due to the Covid-19 epidemic, but some disgruntled business owners have set about to file class actions.On Friday, Prime Minister Kim Boo-kyum vowed to provide additional financial support to sm
Hanmi Pharmaceutical said that the European Medicines Agency (EMA) has granted the orphan drug designation (ODD) to its LAPS Triple Agonist (HM15211) for treating primary sclerosing cholangitis.The ODD designation comes after the company received the ODD designation for HM1521 for treating primary b
Samsung Biologics said Friday that it has broken the highest single order contract once again.According to the company, its contract manufacturing organization (CMO) contract amount with Roche has increased from 444.4 billion won ($374.8 million) to 605.3 billion won.It marked the first time that Sa
Hugel, a medical aesthetic company, said Friday that the Ministry of Trade, Industry and Energy (MOTIE) has approved its cross-border merger and acquisition (M&A) in the form of changes in its largest shareholder.On Aug. 24, the company announced that Leguh Issuer Designated Activity Company, its la
President Moon Jae-in apologized to the public for strengthening quarantine measures to respond to the resurge of the Covid-19 cases."I am sorry for reinforcing social distancing measures again," Moon said on Thursday. "Before shifting to the 'living-with-Covid 19' system, the government failed to s